Cheng Andrew
Insider CIK 1778307 · ABUS Director · AKRO President and CEO, Director · DMRA Director · VERA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DMRA Damora Therapeutics, Inc. | A Award deriv | 2026-08-12 | 2026-08-13 | 30,350 | — | $0 | 30,350 | SEC↗ |
| DMRA Damora Therapeutics, Inc. | A Award deriv | 2026-08-12 | 2026-08-13 | 30,350 | — | $0 | 30,350 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2026-05-21 | 2026-05-26 | 17,084 | — | $0 | 17,084 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 23,809 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,421 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 5,032 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 2,328 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 4,739 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,527 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 292,179 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 374,985 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 233,252 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 165,289 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 10,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 234,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 238,973 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 87,220 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 277,075 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 159,762 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | G Gift | 2025-11-20 | 2025-11-21 | 74,538 | — | $0 | 436,837 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | G Gift | 2025-11-12 | 2025-11-13 | 14,739 | — | $0 | 511,375 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-10-10 | 2025-10-14 | 30,000 | — | $0 | 380,017 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-10-10 | 2025-10-14 | 30,000 | $53.98 | $1.62M | 526,114 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-10-10 | 2025-10-14 | 30,000 | $19.87 | $596.1K | 556,114 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-10-08 | 2025-10-09 | 52,212 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-10-08 | 2025-10-09 | 52,212 | $0.62 | $32.4K | 526,114 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-09-11 | 2025-09-12 | 1,796 | $43.02 | $77.3K | 473,902 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-09-10 | 2025-09-12 | 13,022 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-09-10 | 2025-09-12 | 1,919 | — | $0 | 410,017 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-09-10 | 2025-09-12 | 158 | $44.62 | $7.0K | 475,698 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-09-10 | 2025-09-12 | 13,022 | $6.36 | $82.8K | 503,779 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-09-10 | 2025-09-12 | 1,919 | $19.87 | $38.1K | 505,698 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-09-10 | 2025-09-12 | 22,525 | $42.99 | $968.3K | 483,173 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-09-10 | 2025-09-12 | 7,317 | $44.00 | $321.9K | 475,856 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-08-11 | 2025-08-13 | 18,805 | $48.87 | $919.0K | 491,157 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-08-11 | 2025-08-13 | 400 | $49.44 | $19.8K | 490,757 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-08-11 | 2025-08-13 | 10,795 | $48.07 | $518.9K | 509,962 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-07-10 | 2025-07-11 | 15,314 | $51.73 | $792.2K | 520,757 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-07-10 | 2025-07-11 | 14,686 | $50.57 | $742.7K | 536,071 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2025-06-30 | 2025-07-02 | 890 | $23.87 | $21.2K | 550,757 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-18 | 2025-06-20 | 6,620 | $54.84 | $363.0K | 549,867 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-10 | 2025-06-12 | 15,158 | $54.35 | $823.8K | 564,324 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-10 | 2025-06-12 | 7,837 | $53.99 | $423.1K | 556,487 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-10 | 2025-06-12 | 14,842 | $53.76 | $797.9K | 579,482 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2025-05-14 | 2025-05-16 | 14,000 | — | $0 | 14,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-05-12 | 2025-05-13 | 22,800 | $41.63 | $949.2K | 594,324 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-05-12 | 2025-05-13 | 7,200 | $41.00 | $295.2K | 617,124 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-04-10 | 2025-04-11 | 30,000 | $35.23 | $1.06M | 624,324 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-03-12 | 2025-03-14 | 1,738 | $44.88 | $78.0K | 654,324 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 1,216 | $42.31 | $51.4K | 656,062 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 28,784 | $41.75 | $1.20M | 657,278 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-02-10 | 2025-02-11 | 12,640 | $51.75 | $654.1K | 703,422 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-02-10 | 2025-02-11 | 200 | $55.81 | $11.2K | 686,062 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-02-10 | 2025-02-11 | 6,439 | $52.91 | $340.7K | 696,983 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-02-10 | 2025-02-11 | 9,972 | $53.67 | $535.2K | 687,011 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-02-10 | 2025-02-11 | 749 | $54.55 | $40.9K | 686,262 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-01-27 | 2025-01-29 | 24,242 | $54.56 | $1.32M | 721,820 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-01-27 | 2025-01-29 | 2,381 | $55.53 | $132.2K | 719,439 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-01-27 | 2025-01-29 | 3,377 | $56.89 | $192.1K | 716,062 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-01-23 | 2025-01-27 | 50,000 | — | $0 | 52,212 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-01-23 | 2025-01-27 | 50,000 | $0.62 | $31.0K | 746,062 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2024-12-16 | 2024-12-18 | 295,600 | — | $0 | 295,600 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2024-12-16 | 2024-12-18 | 98,500 | — | $0 | 696,062 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-12-10 | 2024-12-12 | 7,855 | $30.79 | $241.9K | 597,562 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-12-02 | 2024-12-04 | 25,000 | — | $0 | 111,029 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-12-02 | 2024-12-04 | 25,000 | $21.10 | $527.5K | 630,417 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-12-02 | 2024-12-04 | 25,000 | $32.09 | $802.3K | 605,417 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-11-01 | 2024-11-05 | 27,086 | — | $0 | 136,029 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-11-01 | 2024-11-05 | 81,280 | — | $0 | 163,115 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-11-01 | 2024-11-05 | 27,086 | $32.50 | $880.3K | 605,417 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-11-01 | 2024-11-05 | 27,086 | $21.10 | $571.5K | 632,503 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-11-01 | 2024-11-05 | 81,280 | $31.47 | $2.56M | 605,417 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-11-01 | 2024-11-05 | 81,280 | $21.10 | $1.72M | 686,697 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-10-18 | 2024-10-18 | 63,539 | — | $0 | 93,709 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-10-18 | 2024-10-18 | 63,539 | $21.10 | $1.34M | 668,956 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 226 | $32.12 | $7.3K | 605,417 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 63,313 | $31.53 | $2.00M | 605,643 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-10-17 | 2024-10-18 | 3,103 | — | $0 | 157,248 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-10-17 | 2024-10-18 | 3,103 | $21.10 | $65.5K | 608,520 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-10-17 | 2024-10-18 | 3,103 | $31.12 | $96.6K | 605,417 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-10-16 | 2024-10-18 | 24,992 | — | $0 | 160,351 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 24,992 | $31.14 | $778.3K | 605,417 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-10-16 | 2024-10-18 | 24,992 | $21.10 | $527.3K | 630,409 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-13 | 1,738 | $26.18 | $45.5K | 605,417 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-08-16 | 2024-08-20 | 24,538 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-08-16 | 2024-08-20 | 24,538 | $0.62 | $15.2K | 607,155 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2024-06-28 | 2024-07-02 | 1,064 | $19.94 | $21.2K | 582,617 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-06-11 | 2024-06-13 | 7,894 | $22.64 | $178.7K | 581,553 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2024-05-15 | 2024-05-17 | 14,000 | — | $0 | 14,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-03-13 | 2024-03-15 | 1,969 | $28.33 | $55.8K | 589,447 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-03-04 | 2024-03-06 | 57,733 | — | $0 | 10,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-03-04 | 2024-03-06 | 17,267 | — | $0 | 244,395 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-03-04 | 2024-03-06 | 114 | $36.28 | $4.1K | 591,416 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-03-04 | 2024-03-06 | 7,995 | $35.49 | $283.7K | 591,530 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-03-04 | 2024-03-06 | 14,680 | $34.63 | $508.4K | 599,525 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-03-04 | 2024-03-06 | 57,733 | $16.00 | $923.7K | 649,149 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-03-04 | 2024-03-06 | 6,770 | $32.28 | $218.5K | 623,819 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-03-04 | 2024-03-06 | 9,614 | $33.83 | $325.2K | 614,205 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-03-04 | 2024-03-06 | 17,267 | $21.10 | $364.3K | 666,416 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-03-04 | 2024-03-06 | 35,827 | $31.40 | $1.12M | 630,589 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-01-02 | 2024-01-03 | 40,000 | — | $0 | 24,538 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-01-02 | 2024-01-03 | 40,000 | $0.62 | $24.8K | 590,911 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-12-14 | 2023-12-18 | 1,628 | $20.76 | $33.8K | 550,911 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-12-11 | 2023-12-11 | 7,405 | — | $0 | 13,022 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-12-11 | 2023-12-11 | 7,405 | $6.36 | $47.1K | 559,944 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-12-11 | 2023-12-11 | 7,405 | $20.02 | $148.2K | 552,539 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-12-08 | 2023-12-11 | 12,873 | — | $0 | 20,427 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2023-12-08 | 2023-12-11 | 411,936 | — | $0 | 411,936 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2023-12-08 | 2023-12-11 | 91,541 | — | $0 | 552,539 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-12-08 | 2023-12-11 | 12,873 | $20.01 | $257.6K | 460,998 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-12-08 | 2023-12-11 | 12,873 | $6.36 | $81.9K | 473,871 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-12-07 | 2023-12-11 | 6,700 | — | $0 | 33,300 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-12-07 | 2023-12-11 | 6,700 | $20.02 | $134.1K | 460,998 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-12-07 | 2023-12-11 | 6,700 | $6.36 | $42.6K | 467,698 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-10-02 | 2023-10-04 | 25,000 | — | $0 | 40,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 5,300 | $46.88 | $248.5K | 471,830 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-10-02 | 2023-10-04 | 25,000 | $6.36 | $159.0K | 485,998 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 8,868 | $46.06 | $408.5K | 477,130 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 2,662 | $48.56 | $129.3K | 469,168 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 1,700 | $49.71 | $84.5K | 467,468 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 6,470 | $50.56 | $327.1K | 460,998 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-09-13 | 2023-09-25 | 1,682 | $50.34 | $84.7K | 460,998 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-09-01 | 2023-09-18 | 25,000 | — | $0 | 65,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-09-01 | 2023-09-18 | 24,873 | $49.77 | $1.24M | 462,807 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-09-01 | 2023-09-18 | 127 | $50.24 | $6.4K | 462,680 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-09-01 | 2023-09-18 | 25,000 | $6.36 | $159.0K | 487,680 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-08-30 | 2023-08-30 | 15,000 | — | $0 | 102,212 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-08-30 | 2023-08-30 | 15,000 | $0.62 | $9.3K | 462,680 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-08-01 | 2023-08-03 | 25,000 | — | $0 | 90,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-08-01 | 2023-08-03 | 13,679 | $42.85 | $586.1K | 459,001 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-08-01 | 2023-08-03 | 11,321 | $43.52 | $492.7K | 447,680 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-08-01 | 2023-08-03 | 25,000 | $6.36 | $159.0K | 472,680 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-07-03 | 2023-07-06 | 25,000 | — | $0 | 115,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-07-03 | 2023-07-06 | 5,051 | $45.36 | $229.1K | 448,899 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-07-03 | 2023-07-06 | 18,730 | $44.66 | $836.5K | 453,950 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-07-03 | 2023-07-06 | 25,000 | $6.36 | $159.0K | 472,680 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-07-03 | 2023-07-06 | 1,219 | $46.29 | $56.4K | 447,680 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-06-27 | 2023-06-27 | 40,000 | — | $0 | 117,212 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-06-27 | 2023-06-27 | 40,000 | $0.62 | $24.8K | 447,680 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-13 | 2023-06-15 | 1,613 | $55.16 | $89.0K | 407,680 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-06-01 | 2023-06-05 | 3,670 | — | $0 | 140,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-06-01 | 2023-06-05 | 21,330 | — | $0 | 64,538 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-01 | 2023-06-05 | 20,686 | $45.26 | $936.2K | 409,693 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-06-01 | 2023-06-05 | 21,330 | $0.62 | $13.2K | 430,623 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-01 | 2023-06-05 | 400 | $45.90 | $18.4K | 409,293 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-01 | 2023-06-05 | 3,914 | $44.18 | $172.9K | 430,379 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-06-01 | 2023-06-05 | 3,670 | $6.36 | $23.3K | 434,293 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2023-05-10 | 2023-05-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-05-01 | 2023-05-03 | 25,000 | — | $0 | 85,868 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-05-01 | 2023-05-03 | 25,000 | $0.62 | $15.5K | 434,293 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-05-01 | 2023-05-03 | 21,523 | $45.00 | $968.5K | 412,770 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-05-01 | 2023-05-03 | 3,477 | $45.50 | $158.2K | 409,293 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-04-18 | 2023-05-03 | 40,000 | — | $0 | 157,212 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-04-18 | 2023-05-03 | 40,000 | $0.62 | $24.8K | 409,293 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-04-03 | 2023-04-05 | 25,000 | — | $0 | 110,868 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-04-03 | 2023-04-05 | 1,708 | $38.83 | $66.3K | 369,293 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-04-03 | 2023-04-05 | 23,292 | $37.88 | $882.3K | 371,001 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-04-03 | 2023-04-05 | 25,000 | $0.62 | $15.5K | 394,293 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | F Tax w/h | 2023-03-10 | 2023-03-14 | 1,706 | $43.47 | $74.2K | 369,293 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-03-01 | 2023-03-03 | 25,000 | — | $0 | 135,868 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-03-01 | 2023-03-03 | 25,000 | $0.62 | $15.5K | 395,999 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 16,035 | $46.60 | $747.2K | 377,699 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 6,700 | $47.17 | $316.0K | 370,999 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 2,265 | $45.54 | $103.1K | 393,734 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-02-01 | 2023-02-03 | 25,000 | — | $0 | 160,868 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-02-01 | 2023-02-03 | 25,000 | $0.62 | $15.5K | 395,999 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-02-01 | 2023-02-03 | 14,845 | $48.57 | $721.0K | 381,154 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-02-01 | 2023-02-03 | 8,155 | $49.67 | $405.1K | 372,999 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-02-01 | 2023-02-03 | 2,000 | $50.14 | $100.3K | 370,999 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-01-03 | 2023-01-05 | 25,000 | — | $0 | 185,868 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-01-03 | 2023-01-05 | 3,900 | $54.37 | $212.0K | 371,299 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-01-03 | 2023-01-05 | 25,000 | $0.62 | $15.5K | 395,999 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-01-03 | 2023-01-05 | 13,200 | $50.12 | $661.6K | 382,799 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-01-03 | 2023-01-05 | 3,800 | $50.82 | $193.1K | 378,999 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-01-03 | 2023-01-05 | 300 | $54.81 | $16.4K | 370,999 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-01-03 | 2023-01-05 | 800 | $53.09 | $42.5K | 375,199 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-01-03 | 2023-01-05 | 3,000 | $52.03 | $156.1K | 375,999 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-12-16 | 2022-12-20 | 8,500 | — | $0 | 197,212 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-12-16 | 2022-12-20 | 87,220 | — | $0 | 261,662 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-12-16 | 2022-12-20 | 8,500 | $0.62 | $5.3K | 370,999 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-12-09 | 2022-12-13 | 235,580 | — | $0 | 235,580 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2022-12-09 | 2022-12-13 | 52,351 | — | $0 | 362,499 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-12-01 | 2022-12-02 | 10,000 | — | $0 | 210,868 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-12-01 | 2022-12-02 | 10,000 | $46.07 | $460.7K | 310,148 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-12-01 | 2022-12-02 | 10,000 | $0.62 | $6.2K | 320,148 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-11-01 | 2022-11-02 | 10,000 | — | $0 | 220,868 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 500 | $44.02 | $22.0K | 310,148 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 8,900 | $43.47 | $386.9K | 310,648 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 600 | $42.15 | $25.3K | 319,548 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-11-01 | 2022-11-02 | 10,000 | $0.62 | $6.2K | 320,148 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 10,000 | — | $0 | 230,868 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-10-03 | 2022-10-05 | 5,350 | $33.57 | $179.6K | 310,248 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-10-03 | 2022-10-05 | 4,550 | $32.80 | $149.2K | 315,598 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-10-03 | 2022-10-05 | 100 | $34.39 | $3.4K | 310,148 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-10-03 | 2022-10-05 | 10,000 | $0.62 | $6.2K | 320,148 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-09-13 | 2022-09-13 | 87,221 | — | $0 | 174,442 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-09-13 | 2022-09-15 | 60,000 | — | $0 | 240,868 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-09-13 | 2022-09-15 | 60,000 | $0.62 | $37.2K | 370,148 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-09-13 | 2022-09-15 | 16,796 | $26.74 | $449.1K | 353,352 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-09-13 | 2022-09-15 | 43,204 | $27.69 | $1.20M | 310,148 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-09-09 | 2022-09-13 | 87,221 | — | $0 | 87,221 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2022-06-30 | 2022-09-13 | 1,152 | $8.03 | $9.3K | 310,148 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2022-05-24 | 2022-05-26 | 9,925 | — | $0 | 9,925 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-02 | 10,000 | — | $0 | 300,868 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-03-01 | 2022-03-02 | 10,000 | $17.59 | $175.9K | 308,996 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-03-01 | 2022-03-02 | 10,000 | $0.62 | $6.2K | 318,996 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-02-01 | 2022-02-03 | 10,000 | — | $0 | 310,868 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-02-01 | 2022-02-03 | 10,000 | $0.62 | $6.2K | 318,996 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-02-01 | 2022-02-03 | 10,000 | $17.56 | $175.6K | 308,996 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-01-10 | 2022-01-11 | 10,000 | — | $0 | 320,868 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-01-10 | 2022-01-11 | 10,000 | $0.62 | $6.2K | 308,996 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-01-03 | 2022-01-04 | 53,000 | — | $0 | 205,712 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-01-03 | 2022-01-04 | 53,000 | $0.62 | $32.9K | 308,996 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2021-12-08 | 2021-12-10 | 261,662 | — | $0 | 261,662 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-12-02 | 2021-12-03 | 17,500 | $20.18 | $353.1K | 255,996 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-11-02 | 2021-11-03 | 17,500 | $22.57 | $395.0K | 273,496 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-10-04 | 2021-10-05 | 17,500 | $21.54 | $376.9K | 290,996 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-09-02 | 2021-09-03 | 17,500 | $23.89 | $418.1K | 308,496 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-08-03 | 2021-08-04 | 600 | $21.48 | $12.9K | 325,996 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-08-03 | 2021-08-04 | 16,900 | $20.81 | $351.7K | 326,596 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-07-02 | 2021-07-06 | 17,500 | $24.78 | $433.6K | 342,489 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2021-06-03 | 2021-06-07 | 22,000 | — | $0 | 22,000 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion deriv | 2021-05-18 | 2021-05-18 | 17,488 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion | 2021-05-18 | 2021-05-18 | 17,488 | — | $0 | 17,488 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2021-05-13 | 2021-05-17 | 9,925 | — | $0 | 9,925 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-01-10 | 2022-01-11 | 10,000 | $19.55 | $195.5K | 298,996 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2021-01-07 | 2021-01-11 | 20,000 | — | $0 | 258,712 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2021-01-07 | 2021-01-11 | 20,000 | $0.62 | $12.4K | 362,989 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | G Gift | 2020-12-31 | 2021-01-11 | 3,000 | — | $0 | 359,989 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2020-12-28 | 2020-12-29 | 7,480 | — | $0 | 278,712 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2020-12-28 | 2020-12-29 | 7,480 | $0.62 | $4.6K | 342,989 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2020-12-21 | 2020-12-23 | 10,500 | — | $0 | 286,192 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2020-12-21 | 2020-12-23 | 10,500 | $0.62 | $6.5K | 335,509 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | G Gift | 2020-12-15 | 2020-12-23 | 2,500 | — | $0 | 325,009 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | G Gift | 2020-12-11 | 2020-12-23 | 50 | — | $0 | 327,509 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2020-12-08 | 2020-12-09 | 242,500 | — | $0 | 242,500 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2020-06-30 | 2020-12-09 | 1,245 | $17.07 | $21.3K | 327,559 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2020-05-28 | 2020-06-01 | 22,000 | — | $0 | 22,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2019-12-31 | 2020-01-03 | 1,025 | $18.87 | $19.3K | 326,314 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2019-12-13 | 2019-12-13 | 234,000 | — | $0 | 234,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2019-08-17 | 2019-08-20 | 60,000 | — | $0 | 60,000 | SEC↗ |